SOCS proteins and caveolin-1 as negative regulators of endocrine signaling.

Research paper by Jean-François JF Jasmin, Isabelle I Mercier, Federica F Sotgia, Michael P MP Lisanti

Indexed on: 18 Apr '06Published on: 18 Apr '06Published in: Trends in Endocrinology and Metabolism

Abstract

Recently, a new class of regulatory molecules has emerged; these molecules, termed SOCS proteins, function as suppressors of cytokine signaling. SOCS proteins negatively regulate the Janus kinase signal transducer and activator of transcription (JAK-STAT) signaling cascade. Interestingly, it appears that other proteins, such as caveolin-1, can also function as suppressors of cytokine signaling by inhibiting the kinase activity of JAK family members. This might result from the ability of caveolin-1 to function as a broad-spectrum kinase inhibitor through the caveolin-scaffolding domain.

More like this:

Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade.

Research paper by David S DS Park, Hyangkyu H Lee, Philippe G PG Frank, Babak B Razani, Andrew V AV Nguyen, Albert F AF Parlow, Robert G RG Russell, James J Hulit, Richard G RG Pestell, Michael P MP Lisanti

Indexed on: 22 Oct '02

Published on: 22 Oct '02 in Molecular biology of the cell

SOCS, Inflammation, and Autoimmunity.

Research paper by Akihiko A Yoshimura, Mayu M Suzuki, Ryota R Sakaguchi, Toshikatsu T Hanada, Hideo H Yasukawa

Indexed on: 09 May '12

Published on: 09 May '12 in Frontiers in immunology

SOCS: potential immune checkpoint molecules for cancer immunotherapy.

Research paper by Shunsuke S Chikuma, Mitsuhiro M Kanamori, Setsuko S Mise-Omata, Akihiko A Yoshimura

Indexed on: 12 Feb '17

Published on: 12 Feb '17 in Cancer Science